Stop the jab – Johnson & Johnson vaccine rollout paused

805,734,252 – that’s how many doses of the COVID-19 vaccine have been given globally so far as of the 12^th April (from 185 locations), according to Our World in Data. Israel, Bahrain and Chile are leading the way with 54.7%, 24.7% and 24.6% of the population fully vaccinated.

With more and more people getting the jab across the world, the chance of side effects becomes more likely. We have already seen the AstraZeneca vaccine being suspended for use for in few countries. Today, it was announced that the US agencies are calling to pause the Johnson & Johnson vaccine rollout after reports of extremely rare blood clot cases.

Following the FDA and CDC advice, all federal sites in the US have stopped using the vaccine until further investigation.

European Union and South Africa have also confirmed that they will temporally stop the rollout of the Johnson & Johnson jab.

The share price of Johnson & Johnson was down by around 1.34% following the latest news on their vaccine, trading at $159.48 per share the close. The stock is up by 1.57% year-to-date.

Johnson & Johnson – YTD Chart

Source: TradingView